Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-11832-7.pdf
Reference26 articles.
1. Perez, F. et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51, 3471–3484, doi: https://doi.org/10.1128/AAC.01464-06 (2007).
2. Garnacho-Montero, J. & Amaya-Villar, R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 23, 332–339, doi: https://doi.org/10.1097/QCO.0b013e32833ae38b (2010).
3. Hancock, R. E. & Sahl, H. G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24, 1551–1557, doi: https://doi.org/10.1038/nbt1267 (2006).
4. Gentilucci, L., Tolomelli, A. & Squassabia, F. Peptides and peptidomimetics in medicine, surgery and biotechnology. Curr Med Chem 13, 2449–2466 (2006).
5. Melo, M. N., Ferre, R. & Castanho, M. A. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 7, 245–250, doi: https://doi.org/10.1038/nrmicro2095 (2009).
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deciphering the Intracellular Action of the Antimicrobial Peptide A11 via an In-Depth Analysis of Its Effect on the Global Proteome of Acinetobacter baumannii;ACS Infectious Diseases;2024-07-30
2. Antimicrobial Peptides: Potential Alternative to Antibiotics and Overcoming Limitations for Future Therapeutic Applications;International Journal of Peptide Research and Therapeutics;2024-07-02
3. Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia;Critical Reviews in Microbiology;2024-07
4. Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria;Frontiers in Pharmacology;2024-05-20
5. Engineering strategies and challenges of endolysin as an antibacterial agent against Gram‐negative bacteria;Microbial Biotechnology;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3